PREVIOUS
✖
CDSCO’s safety guidelines for Isotretinoin
February 4 , 2019
2038 days
685
0
- The Central Drugs Standard Control Organisation (CDSCO) has issued safety guidelines for Isotretinoin, an oral drug, which is used in the treatment of severe acne.
- It stated that the Drug Controllers of all the States and Union Territories have to monitor the sale, manufacture and distribution of Isotretinoin.
- Isotretinoin can cause birth defects in progeny if not taken without proper guidance.
- Isotretinoin may be sold by retailers only against a dermatologist’s prescription.
Leave a Reply
Your Comment is awaiting moderation.